Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | AMGN | VRTX | REGN | GSK |
| Company | Immunitybio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 2.75 | 298.51 | 468.09 | 547.10 | 38.71 |
| High | 2.91 | 301.66 | 479.34 | 558.38 | 39.12 |
| Low | 2.74 | 291.77 | 466.79 | 545.38 | 38.68 |
| Last | 2.79 | 296.52 | 478.96 | 552.58 | 39.04 |
| Change | +0.08 | -0.48 | +12.60 | +4.83 | +0.56 |
| % Change | +2.95% | -0.16% | +2.70% | +0.88% | +1.46% |
| Volume | 7,879,700 | 2,097,900 | 1,044,400 | 843,700 | 3,624,521 |
| 20-Day Average Volume | 8,031,520 | 2,807,280 | 1,298,100 | 1,033,975 | 5,080,410 |
| Previous Close | 2.71 | 297.00 | 466.36 | 547.75 | 38.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.86 | 289.01 | 452.24 | 526.90 | 39.26 |
| 20-Day Raw Stochastic | 23.02% | 84.81% | 99.11% | 87.76% | 25.83% |
| 20-Day Relative Strength | 50.56% | 56.50% | 61.84% | 52.73% | 50.58% |
| Weighted Alpha | -54.21 | -7.27 | +0.63 | -48.65 | +2.09 |
| Today's Opinion | 48% Sell | 8% Buy | 24% Buy | 64% Sell | 72% Buy |
| Previous Opinion | 48% Sell | 8% Buy | 8% Sell | 80% Sell | 56% Buy |
| Last Month's Opinion | 24% Sell | 40% Sell | 40% Sell | 100% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.56% since 07/01/25 | +2.07% since 07/01/25 | +5.93% since 07/01/25 | +3.30% since 07/01/25 | +0.23% since 07/01/25 |
| Low | 2.55 on 07/02/25 | 289.50 on 07/02/25 | 448.00 on 07/02/25 | 529.69 on 07/02/25 | 37.93 on 07/03/25 |
| High | 3.00 on 07/07/25 | 301.66 on 07/09/25 | 479.34 on 07/09/25 | 559.46 on 07/08/25 | 39.12 on 07/09/25 |
| 1-Month | |||||
| %Chg | -18.90% since 06/09/25 | +2.26% since 06/09/25 | +7.35% since 06/09/25 | +6.76% since 06/09/25 | -4.45% since 06/09/25 |
| Low | 2.50 on 07/01/25 | 267.83 on 06/23/25 | 436.80 on 06/20/25 | 503.25 on 06/18/25 | 37.79 on 06/23/25 |
| High | 3.76 on 06/10/25 | 301.66 on 07/09/25 | 479.34 on 07/09/25 | 559.46 on 07/08/25 | 42.63 on 06/12/25 |
| 3-Month | |||||
| %Chg | +7.31% since 04/09/25 | +1.87% since 04/09/25 | -0.69% since 04/09/25 | -4.19% since 04/09/25 | +13.23% since 04/09/25 |
| Low | 1.83 on 05/07/25 | 261.43 on 05/14/25 | 416.60 on 05/14/25 | 476.49 on 06/05/25 | 32.73 on 04/10/25 |
| High | 3.76 on 06/10/25 | 301.66 on 07/09/25 | 510.77 on 04/30/25 | 617.52 on 05/21/25 | 42.63 on 06/12/25 |
| 6-Month | |||||
| %Chg | +8.98% since 01/08/25 | +12.23% since 01/08/25 | +16.22% since 01/08/25 | -24.67% since 01/08/25 | +15.67% since 01/08/25 |
| Low | 1.83 on 05/07/25 | 260.55 on 01/10/25 | 397.24 on 01/13/25 | 476.49 on 06/05/25 | 31.72 on 01/14/25 |
| High | 4.27 on 02/19/25 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 748.29 on 03/10/25 | 42.63 on 06/12/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,391,900 | 159,698,688 | 119,759,840 | 59,137,824 | 78,781,912 |
| Shares Outstanding, K | 882,620 | 537,706 | 256,797 | 107,965 | 2,047,347 |
| Annual Sales | 14,750,000 | 33,424,000,000 | 11,020,100,000 | 14,202,000,000 | 40,095,390,000 |
| Annual Net Income | -413,560,000 | 4,090,000,000 | -535,600,000 | 4,412,600,000 | 3,290,590,000 |
| Last Quarter Sales | 16,520,000 | 8,149,000,000 | 2,770,200,000 | 3,028,700,000 | 9,466,400,000 |
| Last Quarter Net Income | -129,650,000 | 1,730,000,000 | 646,300,000 | 808,700,000 | 2,045,430,000 |
| 60-Month Beta | 0.08 | 0.49 | 0.41 | 0.33 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 05/12/25 | 4.90 on 05/01/25 | 4.06 on 05/05/25 | 8.22 on 04/29/25 | 1.13 on 04/30/25 |
| Latest Earnings Date | 08/11/25 | 08/05/25 | 08/07/25 | 08/01/25 | 07/30/25 |
| Most Recent Dividend | N/A | 2.380 on 05/16/25 | N/A | 0.880 on 05/20/25 | 0.422 on 05/16/25 |
| Next Ex-Dividends Date | N/A | 05/16/25 | N/A | 05/20/25 | 05/16/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.11 | 0.00 | 14.10 | 9.36 |